Abstract
Background: The elimination of disparities in the burden of cancer is one of the overarching themes of the American Cancer Society 2015 challenge goals. However, not much progress has occurred in this area in the U.S, especially among certain populations. This is an area in which progress has yet to be made, even in 2017.
Methods: In 2014, the CDC BFRSS (Behavioral Risk Factor Surveillance System) conducted cancer survivorship telephone surveys in seven states (Alaska, Iowa, Mississippi, Missouri, Nebraska, Ohio, and Wisconsin). We performed logistic regression to determine the cancer survivorship disparities and socioeconomic status of non-skin cancer patients based on race and ethnicity.
Results: A total of 64,202 people participated in the survey. A total of 3,539 persons (age 18 to 79 years) self-reported being diagnosed with at least one non-skin cancer. The prevalence of non-skin cancer was 3.7%, 7.2%, 7.5%, and 10.5% among Hispanics, other non-Hispanics, black non-Hispanics, and white non-Hispanics, respectively. Compared to the other races, White non-Hispanic race was independently associated with being diagnosed with depression (OR=1.72), unable to work (OR=1.85), daily smoking habits (OR=2.07), and having more than one different type of cancer (OR=2.43 for two types of cancers and OR=2.56 for three or more different cancers).
Conclusions: Non-skin cancer is correlated with socioeconomic status and varies by race/ethnicity. These factors include less education, low income, less family support, and lack of a stable job. However, compared to white non-Hispanics, other races reported essentially the same quality of life.
Citation Format: Jingwei Song, Ligeng Tian, Muktar Aliyu. Correlation between non-skin cancer survival, race/ethnicity, and socioeconomic status in the United States [abstract]. In: Proceedings of the Tenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2017 Sep 25-28; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2018;27(7 Suppl):Abstract nr A47.